Patrizio Armeni
Biographic Data
| ID | 1724232 |
|---|---|
| NAME | Patrizio Armeni |
| GIVEN NAMES | Patrizio |
| FAMILY NAME | Armeni |
| SIGNATURE | ARMENI P |
| AFFILIATIONS | Bocconi University |
| ORCID | 0000-0003-3150-3332 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
The relationship between trust and compliance in the Italian NHS: Results of the People's Voice Survey
BACKGROUND: Public health systems are assessed not only for outcomes but also for their ability to sustain legitimacy and trust. Trust supports long-term cooperation, while mandates can secure immediate adherence but risk eroding trust and weakening future willingness to comply. Italy illustrates this paradox, combining strong outcomes and extensive COVID-19 mandates with comparatively low public confidence. OBJECTIVE: To examine how trust, compl…
Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies
Differing contexts have greatly influenced HTA development in various countries, with considerable effort recently made by international HTA networks (e.g., EUnetHTA) and the European Union (EU) to make HTA a more coherent, equal, and efficient process. Medical devices (MDs) present particular challenges for HTA because of frequent, rapid innovation, outcomes influenced by end-user competence, dynamic pricing and often low-quality scientific evid…
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (COI) studies conducted using a societal perspective. Such an approach contributes to improving countries' understanding of RDs in their entirety as soc…
Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome
Background : Cri du Chat syndrome (CdC) is a rare disease caused by the deletion on the short arm of the chromosome 5, with an incidence of 1:15,000 to 1:50,000 live-born infants. No study at international level has assessed the costs, Quality of Life (QoL) and Disability through standardized quantitative tools. The aim is to estimate economic costs related to CdC from a societal perspective, to assess the QoL and Disability in patients with CdC …
The impact of HTA and procurement practices on the selection and prices of medical devices
Technological innovation in healthcare yields better health outcomes but also drives healthcare expenditure, and governments are struggling to maintain an appropriate balance between patient access to modern care and the economic sustainability of healthcare systems. Health Technology Assessment (HTA) and centralized procurement are increasingly used to govern the introduction and diffusion of new technologies in an effort to make access to innov…
The impact of HTA and procurement practices on the selection and prices of medical devices
Technological innovation in healthcare yields better health outcomes but also drives healthcare expenditure, and governments are struggling to maintain an appropriate balance between patient access to modern care and the economic sustainability of healthcare systems. Health Technology Assessment (HTA) and centralized procurement are increasingly used to govern the introduction and diffusion of new technologies in an effort to make access to innov…
The impact of HTA and procurement practices on the selection and prices of medical devices
Technological innovation in healthcare yields better health outcomes but also drives healthcare expenditure, and governments are struggling to maintain an appropriate balance between patient access to modern care and the economic sustainability of healthcare systems. Health Technology Assessment (HTA) and centralized procurement are increasingly used to govern the introduction and diffusion of new technologies in an effort to make access to innov…
Social Economic Costs, Health-Related Quality of Life and Disability in Patients with Cri Du Chat Syndrome
Background : Cri du Chat syndrome (CdC) is a rare disease caused by the deletion on the short arm of the chromosome 5, with an incidence of 1:15,000 to 1:50,000 live-born infants. No study at international level has assessed the costs, Quality of Life (QoL) and Disability through standardized quantitative tools. The aim is to estimate economic costs related to CdC from a societal perspective, to assess the QoL and Disability in patients with CdC …
Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies
Differing contexts have greatly influenced HTA development in various countries, with considerable effort recently made by international HTA networks (e.g., EUnetHTA) and the European Union (EU) to make HTA a more coherent, equal, and efficient process. Medical devices (MDs) present particular challenges for HTA because of frequent, rapid innovation, outcomes influenced by end-user competence, dynamic pricing and often low-quality scientific evid…
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
In the field of rare diseases (RDs), the evidence standard is often lower than that required by health technology assessment (HTA) and payer authorities. In this commentary, we propose that appropriate economic evaluation for rare disease treatments should be initially informed by cost-of-illness (COI) studies conducted using a societal perspective. Such an approach contributes to improving countries' understanding of RDs in their entirety as soc…
The relationship between trust and compliance in the Italian NHS: Results of the People's Voice Survey
BACKGROUND: Public health systems are assessed not only for outcomes but also for their ability to sustain legitimacy and trust. Trust supports long-term cooperation, while mandates can secure immediate adherence but risk eroding trust and weakening future willingness to comply. Italy illustrates this paradox, combining strong outcomes and extensive COVID-19 mandates with comparatively low public confidence. OBJECTIVE: To examine how trust, compl…
Business (2 works) · Economics (2 works) · Health care (2 works) · Medicine (2 works) · Activity-based costing (1 works) · Agricultural science (1 works) · Agriculture (1 works) · Burden of disease (1 works) · Common Agricultural Policy (1 works) · Computer Science (1 works)